KG

Ketan Gulabrao Albhar

Active Director Additional Director DIN 10979898
DIN 10979898 First appointment Mar 2025 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ketan Gulabrao Albhar

Data last updated:

Ketan Gulabrao Albhar is an Additional Director at Shree Sales Pharma Private Limited (since 2025). The company operates in Trading.

DIN 10979898
Primary Designation Additional Director
Industry Trading
First Appointment 03 Mar 2025
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shree Sales Pharma Private Limited U51909PN2022PTC211622
Additional Director03 Mar 20252022Active

Board colleagues of Ketan Gulabrao Albhar

NameDINCompanyDesignation
Kiran Ramesh Kemkar10979889Shree Sales Pharma Private LimitedAdditional Director
Nikhil Kabra09709310Shree Sales Pharma Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Shree Sales Pharma Private Limited
Premium access

Shareholding and investment profile for Ketan Gulabrao Albhar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ketan Gulabrao Albhar

Ketan Gulabrao Albhar currently holds 1 directorship: Shree Sales Pharma Private Limited (Additional Director, since 03 Mar 2025).

Ketan Gulabrao Albhar was first appointed on 03 Mar 2025 as Additional Director at Shree Sales Pharma Private Limited.

The current boards of Ketan Gulabrao Albhar's companies include Kiran Ramesh Kemkar (Shree Sales Pharma Private Limited), Nikhil Kabra (Shree Sales Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available